Acarbose Cardiovascular Evaluation

News achive

Years :
Search news :


New ACE data presented at the 2017 IDF Congress

News Image

A total of 7534 delegates from 182 countries attended the 2017 IDF Congress in Abu Dhabi.
On Wednesday 6th December, Professor Rury Holman gave an invited talk in the "Latest Cardiovascular Clinical Trials" symposium....

[Read more...]

DTU Director gives keynote lecture at GW-ICC in Beijing

News Image

Professor Rury Holman gave a lecture entitled "New Results from the ACE Trial" during the opening session of the 28th Great Wall of China International Congress of Cardiology (GW-ICC) in Beijing on Friday 13th October 2017. The meeting was attended by 20,285 delegates from 35 countries....

[Read more...]

DTU Director gives plenary lecture at East Meets West Symposium in Hong Kong

News Image

Professor Rury Holman gave an invited plenary lecture in Hong Kong on Sunday 1st October 2017 at the 19th East Meets West Symposium focussing on Diabetes & Cardiovascular Risk Factors. His lecture, entitled "Updates on recent cardiovascular outcome studies in diabetes - from ACE to EXSCEL", reprised the key findings from the ACE trial and EXSCEL, first presented at the EASD in Lisbon on September 13th and 14th 2017 respectively.

DTU Director interviewed by Yang Lan during ACE trial China city tour

News Image

Professor Rury Holman presented the recently released results of the ACE trial at a series of meetings with senior endocrinologists and cardiologists in Shanghai, Beijing, Chengdu, Wuhan and Guangzhou between Sep 24th and 28th. The Beijing Summit meeting, with two-way video links to 20 other Chinese cities, was compèred by the Chinese journalist, Yang Lan....

[Read more...]

ACE trial primary results presented at the 53rd EASD annual meeting in Lisbon

News Image

People with coronary heart disease and impaired glucose tolerance are at increased risk of future cardiovascular events, and of developing type 2 diabetes. In 2006, 37.3% of Chinese adults hospitalised for coronary artery disease had impaired glucose regulation, a major risk factor for diabetes....

[Read more...]


Prof Holman speaks about ACE trial at ADA conference


DTU Director Professor Rury Holman gave an invited talk at the first joint China Medical Tribune and American Diabetes Association (ADA) symposium - 'A Perspective on "Metabetes" from China' - in Philadelphia, USA on Saturday 9th June.

His talk updated attendees about the rationâle for the Acarbose Cardiovascular Evaluation (ACE) Trial, its design, and progress to date....

[Read more...]


ACE is seeking ancillary study proposals...




First National ACE Investigator Meeting


ACE trial holds it's first investigator meeting in China.


First ACE patient enrolled 17th February 2009




Ethics approval received for the Acarbose Cardiovascular Evaluation (ACE) trial


The ACE trial has received ethics approval from the Oxford Tropical Research Ethics Committee (OXTREC). This independent body, based at Oxford University, specializes in the review of trials which do not recruit in Europe....

[Read more...]

Acarbose Cardiovascular Evaluation (ACE) trial launched


The Acarbose Cardiovascular Evaluation (ACE) trial was launched on Friday 11th April 2008 at the 10th South China International Congress of Cardiology in Guangzhou, China. ACE is a multi-centre clinical outcome trial coordinated by the Diabetes Trial Unit and run in China with the guidance of an international Steering Committee of diabetologists and cardiologists....

[Read more...]